Virtu Financial LLC Evolus, Inc. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$7.23 - $10.52 $93,715 - $136,360	12,962 New	12,962 $94,000
Q3 2021 Nov 12, 2021	SELL	$7.36 - $13.67 $216,001 - $401,187	-29,348 Closed	0 $0
Q2 2021 Sep 17, 2021	SELL	$8.42 - $13.96 $15,063 - $24,974	-1,789 Reduced 5.75%	29,348 $371,000
Q1 2021 May 19, 2021	BUY	$3.2 - $16.51 $2,928 - $15,106	915 Added 3.03%	31,137 $404,000
Q4 2020 Feb 24, 2021	BUY	$2.92 - $4.84 $88,248 - $146,274	30,222 New	30,222 $102,000
Q3 2020 Dec 11, 2020	SELL	$3.03 - $5.48 $213,418 - $385,983	-70,435 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$3.53 - $6.17 $141,715 - $247,700	40,146 Added 132.54%	70,435 $373,000
Q4 2019 Feb 04, 2020	BUY	$11.58 - $17.37 $350,746 - $526,119	30,289 New	30,289 $369,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $561M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.